Rodríguez-Ruiz, E.R.; Herrero-Labrador, R.; Fernández-Fernández, A.P.; Serrano-Masa, J.; Martínez-Montero, J.A.; González-Nieto, D.; Hana-Vaish, M.; Benchekroun, M.; Ismaili, L.; Marco-Contelles, J.;
et al. The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy. Int. J. Mol. Sci. 2023, 24, 12254.
https://doi.org/10.3390/ijms241512254
AMA Style
Rodríguez-Ruiz ER, Herrero-Labrador R, Fernández-Fernández AP, Serrano-Masa J, Martínez-Montero JA, González-Nieto D, Hana-Vaish M, Benchekroun M, Ismaili L, Marco-Contelles J,
et al. The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy. International Journal of Molecular Sciences. 2023; 24(15):12254.
https://doi.org/10.3390/ijms241512254
Chicago/Turabian Style
Rodríguez-Ruiz, Emelina R., Raquel Herrero-Labrador, Ana P. Fernández-Fernández, Julia Serrano-Masa, José A. Martínez-Montero, Daniel González-Nieto, Mayuri Hana-Vaish, Mohamed Benchekroun, Lhassane Ismaili, José Marco-Contelles,
and et al. 2023. "The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy" International Journal of Molecular Sciences 24, no. 15: 12254.
https://doi.org/10.3390/ijms241512254
APA Style
Rodríguez-Ruiz, E. R., Herrero-Labrador, R., Fernández-Fernández, A. P., Serrano-Masa, J., Martínez-Montero, J. A., González-Nieto, D., Hana-Vaish, M., Benchekroun, M., Ismaili, L., Marco-Contelles, J., & Martínez-Murillo, R.
(2023). The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy. International Journal of Molecular Sciences, 24(15), 12254.
https://doi.org/10.3390/ijms241512254
